Smartphone Services for Stimulant Use Disorder
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- DynamiCare Health
- Study ID
- NCT07092059
- Status
- Recruiting
Conditions
- Stimulant Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Smartphone digital therapeutic system — DEVICEThis intervention is composed of a smartphone app (Apple iOS or Android type) that prompts patients with Stimulant Use Disorder to (1) complete self-assessment questionnaires in the app about their health, health care needs and the services they receive and other health-related functions in life, (2) read educational modules about health and wellness and answer questions about these readings, (3) speak periodically with a Guide about their use of the app, and (4) take periodic saliva substance tests using video-selfies with their smartphone camera. The intervention includes testing and interviews with the study staff over a 12 month period. There is a follow-up period to measure the longer-term results at 15 months, as well.
Study Details
This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.
Key Dates
- Start date
- Jun 24, 2025
- Status verified
- Jul 2025
- Primary completion
- May 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 270 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: DynamiCare GroupThe main thing participants will do is use an app on their smartphone that might help with recovery. The most important feature of the app is that it allows participants to take a video selfie of themselves taking saliva (spit) drug tests. Then, the app will send these videos to the investigators in a way that is secure and protected. The app also has self-assessments \& reading materials that may be of interest to participants. The intervention group will have an appointment and call tracking module and self-guided CBT therapy modules. The DynamiCare group will be able to report the data collected to their providers and will be able to share the app with people who support them.
- Sham Comparator: Health & Wellness GroupThe main thing participants will do is use an app on their smartphone that might help with their recovery. The most important feature of the app is that it allows participants to take a video selfie of themselves taking saliva (spit) drug tests. Then, the app will send these videos to the investigators in a way that is secure and protected. The app also has self-assessments \& reading materials or modules that may be of interest to participants. The control group will have health and wellness information modules.
Primary Outcome Measure
Saliva drug test outcomes [ Time Frame: Testing will occur over a 15 month period. ]
Central Contacts
- David R Gastfriend, MD860-679-4689
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| This is an At-Home Study - no travel or on-site visits are needed at all; Main Office: 6 Liberty Sq, #2102 | Boston | Massachusetts | 02109 | - |
Find similar trials in Boston, MA
Related Studies
- reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)Recruiting · University of Miami · Miami, Florida
- Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted TreatmentPHASE2 · Recruiting · Washington State University · Spokane, Washington
- Orexin Receptor Antagonism and Sleep in Stimulant Use DisorderPHASE2 · Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug UseRecruiting · Elana Rosenthal · Washington D.C., District of Columbia